European Medicines Agency review of ixazomib (Ninlaro) for the treatment of adult patients with multiple myeloma who have received at least one prior therapy
欧洲药品管理局对伊沙佐米（Ninlaro）用于治疗至少接受过一种既往治疗的多发性骨髓瘤成年患者的审查
期刊:ESMO Open
影响因子:8.3
doi:10.1136/esmoopen-2019-000570
Tzogani, Kyriaki; Florez, Beatriz; Markey, Greg; Caleno, Mariapaola; Olimpieri, Odoardo Maria; Melchiorri, Daniela; Hovgaard, Doris Johanna; Sarac, Sinan Bardakci; Penttilä, Karri; Lapveteläinen, Tuomo; Salmonson, Tomas; Bergh, Jonas; Gisselbrecht, Christian; Pignatti, Francesco
